Published in Infect Immun on June 01, 1978
Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68
Identification of immunogenic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system. Infect Immun (1981) 3.37
Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect Immun (1982) 3.18
Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42
Detection of antibody-accessible proteins on the cell surface of Haemophilus influenzae type b. Infect Immun (1981) 2.41
Monoclonal antibodies directed against a cell surface-exposed outer membrane protein of Haemophilus influenzae type b. Infect Immun (1982) 2.23
A set of two monoclonal antibodies specific for the cell surface-exposed 39K major outer membrane protein of Haemophilus influenzae type b defines all strains of this pathogen. Infect Immun (1983) 1.95
Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b. Infect Immun (1982) 1.83
Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia. Infect Immun (1983) 1.78
Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect Immun (1983) 1.62
Significance of noncapsular antigens in protection against experimental Haemophilus influenzae type b disease: cross-reactivity. Infect Immun (1978) 1.58
Further studies on the immunology of the infant rat experimental model of Haemophilus influenzae type B meningitis. Br J Exp Pathol (1978) 1.17
Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine. Infect Immun (1985) 1.09
Decreased protective efficacy of reduced and alkylated human immune serum globulin in experimental infection with Haemophilus influenzae type b. Infect Immun (1985) 1.01
Bactericidal antibodies against noncapsular components of Haemophilus influenzae. J Clin Microbiol (1983) 0.94
Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence. J Clin Microbiol (1981) 0.85
Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b. Immunology (1989) 0.82
Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model. Infect Immun (1983) 0.82
Role of nasopharyngeal colonization with and without bacteremia in the protection of infant rats against Haemophilus influenzae type b challenge. Infect Immun (1985) 0.81
Antibodies to Haemophilus influenzae type b outer membrane proteins in children with epiglottitis or meningitis and in healthy controls. Infect Immun (1993) 0.80
Experimental meningitis in the rat: Haemophilus influenzae. Infection (1984) 0.80
Outer membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae. Infect Immun (1993) 0.79
Lack of antibacterial activity after intravenous hydrogen peroxide infusion in experimental Escherichia coli sepsis. Infect Immun (1985) 0.75
Rapid differentiation of bacterial meningitides by direct gas-liquid chromatography. J Clin Invest (1982) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res (1973) 3.89
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Role of macrophages in immunological maturation. J Exp Med (1968) 2.27
Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5. N Engl J Med (1975) 2.16
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Prospective evaluation of treatment of Hemophilus influenzae meningitis. J Pediatr (1976) 1.99
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic. J Exp Med (1976) 1.83
Variable susceptibility of Hemophilus influenzae, type B strains to serum bactericidal activity. Proc Soc Exp Biol Med (1972) 1.61
The infant rat as a model of bacterial meningitis. J Infect Dis (1977) 1.44
Immunology of the infant rat experimental model of Haemophilus influenzae type b meningitis. Infect Immun (1977) 1.22
Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976). J Infect Dis (1977) 1.08
Circulating capsular antigen in infant rats infected with Haemophilus influenzae type b. J Infect Dis (1977) 1.07
Effect of neonatal gastrointestinal colonization with cross reacting Escherichia coli on anticapsular antibody production and bacteremia in experimental Haemophilus influenzae type b disease of rats. Infect Immun (1977) 1.06
Commentary: Immunization against Haemophilus influenzae. Pediatrics (1973) 1.05
Cellulitis due to Haemophilus influenzae type B. Antigenemia and antibody responses. Am J Dis Child (1976) 1.00
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
Subtyping isolates of Haemophilus influenzae type b by outer-membrane protein profiles. J Infect Dis (1981) 6.34
Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun (1986) 5.92
A population genetic framework for the study of invasive diseases caused by serotype b strains of Haemophilus influenzae. Proc Natl Acad Sci U S A (1985) 4.48
Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis (1990) 4.06
Outer membrane protein and biotype analysis of pathogenic nontypable Haemophilus influenzae. Infect Immun (1982) 3.78
Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates. J Clin Invest (1983) 3.33
Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b. Infect Immun (1985) 2.99
Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet (1991) 2.63
Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA (1998) 2.50
Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. JAMA (1992) 2.40
Prospects for prevention of Haemophilus influenzae type b disease by immunization. J Infect Dis (1986) 2.31
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health (2001) 2.21
Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health (2000) 2.09
Comparison of outer-membrane protein subtypes and biotypes of isolates of Haemophilus influenzae type b. J Infect Dis (1981) 2.07
Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA (1993) 2.05
Outer-membrane protein subtypes of Haemophilus influenzae type b and spread of disease in day-care centers. J Infect Dis (1981) 2.03
Human antibody responses to lipopolysaccharide after meningitis due to Haemophilus influenzae type b. J Infect Dis (1982) 1.87
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86
Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia. Infect Immun (1983) 1.78
Differences in surface expression of NspA among Neisseria meningitidis group B strains. Infect Immun (1999) 1.76
Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr (1993) 1.69
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Importance of complement source in measuring meningococcal bactericidal titers. Clin Diagn Lab Immunol (2001) 1.57
Spread of Haemophilus influenzae type b: recent epidemiologic and therapeutic considerations. J Pediatr (1980) 1.55
Second episodes of Haemophilus influenzae type b disease following rifampin prophylaxis of the index patients. Pediatr Infect Dis J (1987) 1.47
Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa. J Infect Dis (2009) 1.47
Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates. J Immunol (1995) 1.47
Antibody responses to Haemophilus influenzae type b polysaccharide vaccine in relation to Km(1) and G2m(23) immunoglobulin allotypes. J Infect Dis (1986) 1.43
Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b. Pediatr Res (1990) 1.43
Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein. Lancet (1986) 1.42
Complement-mediated bactericidal activity of human antibodies to poly alpha 2-->8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. J Infect Dis (1995) 1.41
Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults. J Pediatr (1984) 1.41
Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol (1987) 1.38
Haemophilus influenzae type B disease in a day care center: eradication of carrier state by rifampin. Pediatrics (1979) 1.37
Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine. N Engl J Med (1986) 1.36
Do children with recurrent Haemophilus influenzae otitis media become infected with a new organism or reacquire the original strain? J Pediatr (1984) 1.36
Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996. J Acquir Immune Defic Syndr (1999) 1.36
Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J Infect Dis (1990) 1.35
Comparison of outer membrane protein subtypes of Haemophilus influenzae type b isolates from healthy children in the general population and from diseased patients. J Clin Microbiol (1983) 1.34
Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. J Pediatr (1988) 1.30
Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype. J Clin Invest (1984) 1.28
Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease. J Infect Dis (1980) 1.26
Infectious diseases and child day care. Pediatrics (1984) 1.25
An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide. J Clin Invest (1991) 1.24
Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Infect Immun (1984) 1.24
Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B. Infect Immun (2001) 1.21
Outer membrane protein subtypes and biotypes of Haemophilus influenzae type b: relation between strains isolated in 1934-1954 and 1977-1980. J Infect Dis (1983) 1.20
Comparison of rifampin and ampicillin in day care center contacts of Haemophilus influenzae type b disease. Pediatrics (1980) 1.17
Rifampin prophylaxis for contacts of Haemophilus influenzae type b disease. JAMA (1981) 1.14
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B. Clin Vaccine Immunol (2008) 1.13
A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides. Immunol Invest (2001) 1.13
Antimicrobial susceptibility patterns of Haemophilus isolates from children in eleven developing nations. BOSTID Haemophilus Susceptibility Study Group. Bull World Health Organ (1990) 1.12
Infectious arthritis in the neonate caused by Haemophilus influenzae. Am J Dis Child (1975) 1.12
Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F. Infect Immun (1997) 1.12
Countercurrent immunoelectrophoresis in the diagnosis of Haemophilus influenzae type b infection: relationship of detection of capsular antigen to age, antibody response, and therapy. Am J Dis Child (1977) 1.11
A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass. J Clin Invest (1990) 1.11
Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants. Pediatrics (1987) 1.11
Imperfect memory and the development of Haemophilus influenzae type B disease. Pediatr Infect Dis J (2001) 1.10
Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine. Infect Immun (1985) 1.09
Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts. Pediatrics (1985) 1.09
Lipopolysaccharide gel profiles of Haemophilus influenzae type b are not stable epidemiologic markers. J Clin Microbiol (1986) 1.07
Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. J Immunol (1993) 1.07
Circulating capsular antigen in infant rats infected with Haemophilus influenzae type b. J Infect Dis (1977) 1.07
Concentrations of antibodies in paired maternal and infant sera: relationship to IgG subclass. J Pediatr (1987) 1.04
Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries. Rev Infect Dis (1989) 1.03
Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease. J Immunogenet (1985) 1.02
Relation of age, race, and allotype to immunoglobulin subclass concentrations. Pediatr Res (1985) 1.02
Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease. FEMS Immunol Med Microbiol (1999) 1.01
Haemophilus influenzae type b polysaccharide vaccines. J Pediatr (1985) 1.00
Cellulitis due to Haemophilus influenzae type B. Antigenemia and antibody responses. Am J Dis Child (1976) 1.00
A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency. J Pediatr (2001) 1.00
The biology of Haemophilus influenzae type b vaccination failure. J Infect Dis (1992) 1.00
Increased voluntary running and decreased motor coordination in mice after neonatal corticosterone implantation. Exp Neurol (1968) 0.99
Development of Haemophilus influenzae type b meningitis in a household contact treated with rifampin. Pediatrics (1982) 0.99
Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. J Pediatr (1987) 0.98
Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain. Infect Immun (1995) 0.97
Prospective surveillance of Haemophilus influenzae type b disease in Dallas County, Texas, and in Minnesota. Pediatrics (1987) 0.97
Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics (1998) 0.97
Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae. J Immunol (1986) 0.96
Nosocomial spread of Haemophilus influenzae type b infection documented by outer membrane protein subtype analysis. J Pediatr (1983) 0.96
An improved method of digitoxin therapy. Ann Intern Med (1970) 0.94
Subnormal serum concentrations of IgG2 in children with frequent infections associated with varied patterns of immunologic dysfunction. J Pediatr (1990) 0.94
Outer membrane protein subtypes and investigation of recurrent Haemophilus influenzae type b disease. J Pediatr (1982) 0.91
Heroin sniffers: between two worlds. J Psychoactive Drugs (1989) 0.89
Siblings of patients with Haemophilus meningitis have impaired anticapsular antibody responses to Haemophilus vaccine. J Pediatr (1983) 0.89
Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota. JAMA (1988) 0.89
Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine? JAMA (2000) 0.89
Correlation of serum immunoglobulin subclass concentrations with antibody responses of children to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine. J Clin Immunol (1985) 0.88
Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res (1990) 0.88
Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1. Infect Immun (1994) 0.88
Decline in serum antibody to the capsule of Haemophilus influenzae type b in the immediate postimmunization period. J Pediatr (1989) 0.87
Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak. Pediatrics (1986) 0.87
Molecular mimetics of Neisseria meningitidis serogroup B polysaccharide. Int Rev Immunol (2001) 0.86
Haemophilus influenzae type b infections in day care attendees: implications for management. Rev Infect Dis (1986) 0.85
Phase I study of the immunogenicity and safety of conjugated Hemophilus influenzae type b vaccines in the elderly. Vaccine (1997) 0.85
Pneumococcal vaccine in children. Clin Pediatr (Phila) (1980) 0.85
DNA, RNA, and cholesterol increases in cerebrum and cerebellum during development of human fetus. Brain Res (1969) 0.84
Excretion of Haemophilus influenzae type b polysaccharide antigen in urine of healthy nasopharyngeal carriers. Pediatr Res (1989) 0.84
Urinary tract infection due to Hemophilus influenzae, type b. J Pediatr (1974) 0.83